NCT01073553View on ClinicalTrials.gov

Cross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin Capsules

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Anti-Infective Agents
Interventions
DRUG

Cephalexin capsules (Optocef, BAYO5448 )

Single dose of 500 mg (One 500 mg capsule)

DRUG

Cephalexin capsules (Keflex)

Single dose of 500 mg (Two 250 mg capsules)

Trial Locations (1)

58256

Morelia

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
collaborator

Corporación Bonima S.A. de C.V.

INDUSTRY

lead

Bayer

INDUSTRY